medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/1607-0763-2018-5-55-64medvis-655Research ArticleБРЮШНАЯ ПОЛОСТЬABDOMENХолангиокарцинома: классификации и стадированиеCholangiocarcinoma: classification and stagingЩеголевА. И.ShchegolevA. I.

доктор мед. наук, профессор, заведующий патологоанатомическим отделением

профессор кафедры патологической анатомии и клинической патологической анатомии лечебного факультета 

117997 Москва, ул. Академика Опарина, д. 4

8-495-531-44-44

doct. of med. sci., Professor, Head of Morbid Anatomy

professor of the Department of pathological anatomy and clinical pathological anatomy of the medical faculty

117997 Moscow, Russia, Acedemika Oparina str., 4

+7-495-531-44-44

ashegolev@oparina4.ruТумановаУ. Н.TumanovaU. N.

канд. мед. наук, старший научный сотрудник патологоанатомического отделения

cand. of med. sci., senior researcher, Department of Morbid Anatomy

КармазановскийГ. Г.KarmazanovskyG. G.

член-корр. РАН, доктор мед. наук, профессор, руководитель отдела лучевых методов диагностики

сorresponding member of the Russian Academy of Sciences, doct. of med. sci., Professor, Head of Radiology Department

МишнёвО. Д.MishnevO. D.

доктор мед. наук, профессор, заведующий кафедрой патологической анатомии и клинической патологической анатомии лечебного факультета

doct. of med. sci., Professor, Head of the Department of pathological anatomy and clinical pathological anatomy of the medical faculty

ФГБУ “Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова” ГБОУ ВПО “Российский национальный исследовательский медицинский университет имени Н.И. Пирогова”РоссияAcademician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology N.I. Pirogov Russian National Research Medical UniversityRussian FederationФГБУ “Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова”РоссияAcademician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and PerinatologyRussian FederationФГБУ “Национальный медицинский исследовательский центр хирургии имени А.В. Вишневского”РоссияA.V.Vishnevsky National Medical Research Center for SurgeryRussian FederationГБОУ ВПО “Российский национальный исследовательский медицинский университет имени Н.И. Пирогова”РоссияN.I. Pirogov Russian National Research Medical UniversityRussian Federation201828102018055564Copyright © Щеголев А.И., Туманова У.Н., Кармазановский Г.Г., Мишнёв О.Д., 20182018Щеголев А.И., Туманова У.Н., Кармазановский Г.Г., Мишнёв О.Д.Shchegolev A.I., Tumanova U.N., Karmazanovsky G.G., Mishnev O.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/655

Основными классификациями холангиокарциномы (ХКЦ) в настоящее время являются TNM-классификация, а также классификации Bismuth–Corlette и MSKCC. Приведены категории T, N и M и характеристики стадий ХЦК проксимальных и дистальных желчных протоков, представленные в современном 8-м издании Международной TNM-классификации. TNM-класси фикация является наиболее общепринятой для разработки методов лечения и определения прогноза заболевания. Классификация Bismuth–Corlette, характеризующая ХКЦ желчных протоков в области ворот печени, используется для определения вида и объема оперативного вмешательства. MSKCC-классификация ХКЦ проксимальных желчных протоков предназначена для оценки прогноза резектабельности, риска развития метастазов и долгосрочной выживаемости больных.

The main classifications of cholangiocarcinoma (CC) are currently the TNM classification, as well as the Bismuth–Corlette and MSKCC classifications. The criteria of T, N and M categories and characteristics of the stages of cholangiocarcinoma of the proximal and distal bile ducts, which are specified in the modern 8th edition of the international TNM classification, are presented. TNM classification is the most common for the development of treatment methods and the determination of disease prognosis. The Bismuth–Corlette classification, which characterizes the CC of the bile ducts in the region of the gate of the liver, is used to determine the type and volume of surgery. MSKCC classification of the CC of proximal bile ducts is designed to assess the prognosis of resectability, the risk of metastases and long-term survival of patients.

желчные протокипеченьхолангиокарциномаклассификацияbile ductslivercholangiocarcinomaclassificationReferencesKhan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 2002; 37: 806–813.Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 2002; 37: 806–813.Saha S.K., Zhu A.X., Fuchs C.S., Brooks G.A. Forty-year trends in cholangiocarcinoma incidence in the US: intrahepatic disease on the rise. Oncologist. 2016; 21: 594–599. DOI: 10.1634/theoncologist.2015-0446.Saha S.K., Zhu A.X., Fuchs C.S., Brooks G.A. Forty-year trends in cholangiocarcinoma incidence in the US: intrahepatic disease on the rise. Oncologist. 2016; 21: 594–599. DOI: 10.1634/theoncologist.2015-0446.Sripa B., Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr. Opin. Gastroenterol. 2008; 24: 349–356. DOI: 10.1097/MOG.0b013e3282fbf9b3.Sripa B., Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr. Opin. Gastroenterol. 2008; 24: 349–356. DOI: 10.1097/MOG.0b013e3282fbf9b3.Shaib Y., El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin. Liver Dis. 2004; 24: 115–125. DOI: 10.1055/s-2004-828889.Shaib Y., El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin. Liver Dis. 2004; 24: 115–125. DOI: 10.1055/s-2004-828889.West J., Wood H., Logan R.F., Quinn M., Aithal G.P. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br. J. Cancer. 2006; 94: 1751–1758. DOI: 10.1038/sj.bjc.6603127.West J., Wood H., Logan R.F., Quinn M., Aithal G.P. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br. J. Cancer. 2006; 94: 1751–1758. DOI: 10.1038/sj.bjc.6603127.Bergquist A., von Seth E. Epidemiology of cholangiocarcinoma. Best. Pract. Res. Clin. Gastroenterol. 2015; 29: 221–232. DOI: 10.1016/j.bpg.2015.02.003.Bergquist A., von Seth E. Epidemiology of cholangiocarcinoma. Best. Pract. Res. Clin. Gastroenterol. 2015; 29: 221–232. DOI: 10.1016/j.bpg.2015.02.003.Bertuccio P., Bosetti C., Levi F., Decarli A., Negri E., La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol. 2013; 24: 1667–1674. DOI: 10.1093/annonc/mds652.Bertuccio P., Bosetti C., Levi F., Decarli A., Negri E., La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol. 2013; 24: 1667–1674. DOI: 10.1093/annonc/mds652.Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S.J., Youssef B.A.M, Klimstra D., Blumgart L.H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–517.Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S.J., Youssef B.A.M, Klimstra D., Blumgart L.H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–517.Щеголев А.И., Мишнев О.Д. Онкоморфология печени. М.: Изд-во РГМУ, 2006. 252 с.Shchegolev A. I., Mishnev O. D. Oncomorphology liver. M.: Publishing RSSU, 2006; 252 p. (In Russian)Chung Y.E., Kim M.J., Park Y.N., Choi J.Y., Pyo J.Y., Kim Y.C., Cho H.J., Kim K.A., Choi S.Y. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009; 3: 683–700. DOI: 10.1148/rg.293085729.Chung Y.E., Kim M.J., Park Y.N., Choi J.Y., Pyo J.Y., Kim Y.C., Cho H.J., Kim K.A., Choi S.Y. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009; 3: 683–700. DOI: 10.1148/rg.293085729.Акинфиев Д.М., Бахмутова Е.Е., Беляков Г.А. и др. Лучевая диагностика и малоинвазивное лечение механической желтухи. М.: Радиология-пресс, 2010. 288 с.Akinfiev D.M., Bahmutova E.E., Beliakov G.A. Radiation diagnosis and minimally invasive treatment of mechanical jaundice. M.: Radiologia-press, 2010. 288 p. (In Russian)Международная статистическая классификация болезней и проблем, связанных со здоровьем; 10-й пересмотр. Женева: ВОЗ, 2003. Т.1.Международная статистическая классификация болезней и проблем, связанных со здоровьем; 10-й пеTNM classification of malignant tumours. Ed. J.D. Brierley, M.K. Gospodarowicz., Ch. Wittekind – 8th ed. NY: Wiley-Blackwell, 2017. 272 p.ресмотр. Женева: ВОЗ, 2003. Т.1. (In Russian)AJCC cancer staging manual, eighth ed. Ed. chief M.B. Amin. Springer, 2017. 1024 p.TNM classification of malignant tumours. Ed. J.D. Brierley, M.K. Gospodarowicz., Ch. Wittekind – 8th ed. NY: Wiley-Blackwell, 2017. 272 p.Rizvi S., Khan S.A., Hallemeier C.L., Kelley R.K., Gores G.J. Cholangiocarcinoma – evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 2018; 15: 95–111. DOI: 10.1038/nrclinonc.2017.157.AJCC cancer staging manual, eighth ed. Ed. chief M.B. Amin. Springer, 2017. 1024 p.Щеголев А.И., Туманова У.Н., Кармазановский Г.Г. Восьмое издание Международной TNM-классификации злокачественных опухолей печени. Медицинская визуалицация. 2017; 6: 41–48. DOI: 10.24835/1607-0763-2017-6-41-48.Rizvi S., Khan S.A., Hallemeier C.L., Kelley R.K., Gores G.J. Cholangiocarcinoma – evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 2018; 15: 95–111. DOI: 10.1038/nrclinonc.2017.157.American College of Radiology. Quality and safety resources: Liver Imaging–Reporting and Data System. Available at: http://www.acr.org/Quality-Safety/Resources/LIRADS. Accessed April 22, 2012.Shchegolev A.I., Tumanova U.N., Karmazanovsky G.G. Eighth edition of the International TNM classification of malignant tumors of the liver. Medical Visualization. 2017; 6: 41–48. DOI: 10.24835/1607-0763-2017-6-41-48. (In Russian)Туманова У.Н., Кармазановский Г.Г., Щеголев А.И. Система LI-RADS при компьютерно-томографической диагностике гепатоцеллюлярного рака. Медицинская визуализация. 2014; 6: 44–50.American College of Radiology. Quality and safety resources: Liver Imaging–Reporting and Data System. Available at: http://www.acr.org/Quality-Safety/Resources/LIRADS. Accessed April 22, 2012.Joo I., Lee J.M. Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of gadoxetic acid-enhanced MRI. Liver Cancer. 2016; 5: 67–87. DOI: 10.1159/000367750.Tumanova U.N., Karmazanovsky G.G., Shchegolev A.I. LIRADS system for computer-tomographic diagnosis of hepatocellular carcinoma. Medical Visualization. 2014; 6: 44–50. (In Russian)Kajiyama K., Maeda T., Takenaka K., Sugimachi K., Tsuneyoshi M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of “scirrhous-type” and “nonscirrhous-type” growth. Am. J. Surg. Pathol. 1999; 23: 892–902.Joo I., Lee J.M. Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of gadoxetic acid-enhanced MRI. Liver Cancer. 2016; 5: 67–87. DOI: 10.1159/000367750.Razumilava N., Gores G.J. Classification, diagnosis, and management of cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 2013; 11: 13–21. DOI: 10.1016/j.cgh.2012.09.009.Kajiyama K., Maeda T., Takenaka K., Sugimachi K., Tsuneyoshi M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of “scirrhous-type” and “nonscirrhous-type” growth. Am. J. Surg. Pathol. 1999; 23: 892–902.Joo I., Lee J.M., Yoon J.H. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: Recent advances and challenges. Radiology. 2018; 288: 7–13. DOI: 10.1148/radiol.2018171187.Razumilava N., Gores G.J. Classification, diagnosis, and management of cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 2013; 11: 13–21. DOI: 10.1016/j.cgh.2012.09.009.Park H.J., Kim Y.K., Park M.J., Lee W.J. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom. Imaging. 2013; 38: 793–801. DOI: 10.1007/s00261-012-9943-x.Joo I., Lee J.M., Yoon J.H. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: Recent advances and challenges. Radiology. 2018; 288: 7–13. DOI: 10.1148/radiol.2018171187.Туманова У.Н., Кармазановский Г.Г., Дубова Е.А., Щёголев А.И. Сравнительный анализ степени васкуляризации гепатоцеллюлярного рака и очаговой узловой гиперплазии печени по данным компьютерно-томографического и морфологического исследований. Вестник Российской академии медицинских наук. 2013; 12: 9–15.Park H.J., Kim Y.K., Park M.J., Lee W.J. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom. Imaging. 2013; 38: 793–801. DOI: 10.1007/s00261-012-9943-x.Туманова У.Н., Кармазановский Г.Г., Щёголев А.И. Компьютерно-томографические характеристики степени васкуляризации гепатоцеллюлярного рака. Медицинская визуализация. 2013; 1: 52–58.Tumanova U.N., Karmazanovsky G.G., Dubova E.A., Shchegolev A.I. Comparative analysis of vascularization degree of hepatocellular carcinoma and focal nodular hyperplasia of the liver according to computed tomography and morphological studies. Vestnik Rossijskoj akademii medicinskix nauk. 2013; 12: 9–15. (In Russian)Guglielmi A., Ruzzenente A., Campagnaro T., Pachera S., Conci S., Valdegamberi A., Sandri M., Iacono C. Prognostic significance of lymph node ratio after resection of perihilar cholangiocarcinoma. HPB (Oxford). 2011; 13: 240–245. DOI: 10.1111/j.1477-2574.2010.00277.x.Tumanova U.N., Karmazanovsky G.G., Shchegolev A.I. Characterize the degree of vascularization of hepatocellular carcinoma at spiral computed tomography. Medical Visualization. 2013; 1: 52–58. (In Russian)Guglielmi A., Ruzzenente A., Bertuzzo F., Iacono C. Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary Surg. Nutr. 2013; 2: 281–283. DOI: 10.1001/jamasurg.2016.1769.Guglielmi A., Ruzzenente A., Campagnaro T., Pachera S., Conci S., Valdegamberi A., Sandri M., Iacono C. Prognostic significance of lymph node ratio after resection of perihilar cholangiocarcinoma. HPB (Oxford). 2011; 13: 240–245. DOI: 10.1111/j.1477-2574.2010.00277.x.Ruzzenente A., Bagante F., Ardito F., Campagnaro T., Scoleri I., Conci S., Iaconoa C., Giuliante F., Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018; 164: 244–250. DOI: 10.1016/j.surg.2018.03.012.Guglielmi A., Ruzzenente A., Bertuzzo F., Iacono C. Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary Surg. Nutr. 2013; 2: 281–283. DOI: 10.1001/jamasurg.2016.1769.Jun S.-Y., Sung Y.-N., Lee J.H., Park K.-M., Lee Y.-J., Hong S.-M. Validation of the Eighth American Joint Committee on Cancer Staging System for distal bile duct carcinoma. Cancer Res. Treat. 2018; mar 2. DOI: 10.4143/crt.2017.595.Ruzzenente A., Bagante F., Ardito F., Campagnaro T., Scoleri I., Conci S., Iaconoa C., Giuliante F., Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018; 164: 244–250. DOI: 10.1016/j.surg.2018.03.012.Moon A., Choi D.W., Choi S.H., Heo J.S., Jang K.T. Validation of T stage according to depth of invasion and N stage subclassification based on number of metastatic lymph nodes for distal extrahepatic bile duct (EBD) carcinoma. Medicine (Baltimore). 2015; 94: e2064.DOI: 10.1097/MD.0000000000002064.Jun S.-Y., Sung Y.-N., Lee J.H., Park K.-M., Lee Y.-J., Hong S.-M. Validation of the Eighth American Joint Committee on Cancer Staging System for distal bile duct carcinoma. Cancer Res. Treat. 2018; mar 2. DOI: 10.4143/crt.2017.595.Kiriyama M., Ebata T., Aoba T., Kaneoka Y., Arai T., Shimizu Y., Nagino M., Nagoya Surgical Oncology Group. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br. J. Surg. 2015; 102: 399–406. DOI: 10.1002/bjs.9752.Moon A., Choi D.W., Choi S.H., Heo J.S., Jang K.T. Validation of T stage according to depth of invasion and N stage subclassification based on number of metastatic lymph nodes for distal extrahepatic bile duct (EBD) carcinoma. Medicine (Baltimore). 2015; 94: e2064. DOI: 10.1097/MD.0000000000002064.Kang J.S., Lee S., Son D., Han Y., Lee K.B., Kim J.R., Kwon W., Kim S.W., Jang J.Y. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system. J. Hepatobiliary Pancreat. Sci. 2018; 25: 124–130. DOI: 10.1002/jhbp.520.Kiriyama M., Ebata T., Aoba T., Kaneoka Y., Arai T., Shimizu Y., Nagino M., Nagoya Surgical Oncology Group. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br. J. Surg. 2015; 102: 399–406. DOI: 10.1002/bjs.9752.Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am. J. Med. 1965; 38: 241–256.Kang J.S., Lee S., Son D., Han Y., Lee K.B., Kim J.R., Kwon W., Kim S.W., Jang J.Y. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system. J. Hepatobiliary Pancreat. Sci. 2018; 25: 124–130. DOI: 10.1002/jhbp.520.Bismuth H., Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg. Gynecol. Obstet. 1975; 140: 170–178.Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am. J. Med. 1965; 38: 241–256.Tsao J.I., Nimura Y., Kamiya J., Hayakawa N., Kondo S., Nagino M., Miyachi M., Kanai M., Uesaka K., Oda K., Rossi R.L., Braasch J.W., Dugan J.M. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann. Surg. 2000; 232: 166–174.Bismuth H., Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg. Gynecol. Obstet. 1975; 140: 170–178.Soares K.C., Kamel I., Cosgrove D.P., Herman J.M., Pawlik T.M. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg. Nutr. 2014; 3: 18–34. DOI: 10.3978/j.issn.2304-3881.2014.02.05.Tsao J.I., Nimura Y., Kamiya J., Hayakawa N., Kondo S., Nagino M., Miyachi M., Kanai M., Uesaka K., Oda K., Rossi R.L., Braasch J.W., Dugan J.M. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann. Surg. 2000; 232: 166–174.Каштанова Н.Ю., Плетнева В.Ю., Гепалова Ю.Ю, Современный взгляд на проблему диагностики опухоли Клатскина (обзор литературы). Медицинская визуализация. 2016; 6: 52–61.Soares K.C., Kamel I., Cosgrove D.P., Herman J.M., Pawlik T.M. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg. Nutr. 2014; 3: 18–34. DOI: 10.3978/j.issn.2304-3881.2014.02.05.Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S.J, Youssef B.A.M., Klimstra D., Blumgart L.H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–517.Каштанова Н.Ю., Плетнева В.Ю., Гепалова Ю.Ю, Современный взгляд на проблему диагностики опухоли Клатскина (обзор литературы). Медицинская визуализация. 2016; 6: 52–61.Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S.J, Youssef B.A.M., Klimstra D., Blumgart L.H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–517.Jarnagin W.R., Fong Y., DeMatteo R.P., Gonen M., Burke E.C., Bodniewicz B.S.J, Youssef B.A.M., Klimstra D., Blumgart L.H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 2001; 234: 507–517.

The authors declare that there are no conflicts of interest present.